Nagarika Generics India Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 23-12-2024
- Paid Up Capital ₹ 2.24 Cr
as on 23-12-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Nagarika Generics India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
Muralidhara Bindumalyam, Kishore Rajagopal, Anuradha Bindumalyam, and Four other members serve as directors at the Company.
- CIN/LLPIN
U51909KA2020PTC134808
- Company No.
134808
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nagarika Generics India?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muralidhara Bindumalyam  | Director | 10-Jun-2020 | Current |
Kishore Rajagopal  | Additional Director | 19-Jun-2020 | Current |
| Anuradha Bindumalyam | Director | 10-Jun-2020 | Current |
| Muralidhara Ashwini | Director | 10-Jun-2020 | Current |
| Bindumalyam Muralidhar | Director | 10-Jun-2020 | Current |
| Muntimadagu Manjunatha | Director | 10-Jun-2020 | Current |
Financial Performance of Nagarika Generics India.
Nagarika Generics India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nagarika Generics India?
Unlock access to Nagarika Generics India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Trinity Medicity India Private LimitedActive 17 years 3 monthsMuralidhara Bindumalyam and Anuradha Bindumalyam are mutual person
- Bgs Renewable Energy And Infra Private LimitedActive 11 months 19 days
Muralidhara Bindumalyam is a mutual person
- Shariff Nursing Home Private LimitedActive 43 years 1 month
Muralidhara Bindumalyam and Anuradha Bindumalyam are mutual person
- Trinity Heart Foundation Private LimitedActive 24 years 11 months
Muralidhara Bindumalyam, Anuradha Bindumalyam and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nagarika Generics India?
Nagarika Generics India has a workforce of 3 employees as of Apr 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nagarika Generics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nagarika Generics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.